Back to User profile » Dr Eva González-Haba
Papers published by Dr Eva González-Haba:
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain
Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A
ClinicoEconomics and Outcomes Research 2018, 10:773-790
Published Date: 14 November 2018
Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene
García-González X, López-Tarruella S, García MI, González-Haba E, Blanco C, Salvador-Martin S, Jerez Y, Thomas F, Jarama M, Sanjurjo Sáez M, Martín M, López-Fernández LA
Cancer Management and Research 2018, 10:4517-4522
Published Date: 11 October 2018
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D
ClinicoEconomics and Outcomes Research 2016, 8:475-484
Published Date: 21 September 2016